HHS spokesperson abruptly resigns, reportedly after clash with RFK

A key spokesperson for the U.S. Department of Health and Human Services (HHS) has announced his resignation, less than two weeks after taking the job.

Tom Corry was serving as the assistant secretary of public affairs at HHS, having been sworn in during President Donald Trump’s second term. Corry celebrated the news in a LinkedIn post at the time, writing that he was “thankful that I’ll be part of the team that is going to work to make America healthy again, and on making healthcare more affordable and accessible.”

Corry served as the senior adviser and director of communications, a similar role, for the Centers for Medicare & Medicaid Services (CMS) during Trump’s first term.

His resignation was abrupt and unexpected, also coming in the form of a LinkedIn post.

“I want to announce to my friends and colleagues that last Friday I announced my resignation effective immediately. To my colleagues at HHS, I wish you the best and great success,” Corry wrote.

While no reason was given, Politico reported his departure came after a clash with HHS Director Robert F. Kennedy Jr. and his principal deputy chief of staff, Stefanie Spear. The outlet cited two sources familiar with the matter as the basis for that claim.

HealthExec has reached out to HHS for comment.

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.